Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · IEX Real-Time Price · USD
1.320
+0.110 (9.09%)
At close: Apr 19, 2024, 4:00 PM
1.350
+0.030 (2.27%)
After-hours: Apr 19, 2024, 6:01 PM EDT
Ekso Bionics Holdings Market Cap
Ekso Bionics Holdings has a market cap or net worth of $23.63 million as of April 19, 2024. Its market cap has increased by 9.92% in one year.
Market Cap
23.63M
Enterprise Value
22.16M
1-Year Change
9.92%
Ranking
Category
Stock Price
$1.32
Market Cap Chart
Since March 31, 2014, Ekso Bionics Holdings's market cap has decreased from $250.40M to $23.63M, a decrease of -90.56%. That is a compound annual growth rate of -20.91%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 19, 2024 | 23.60M | 8.76% |
Apr 18, 2024 | 21.70M | -5.24% |
Apr 17, 2024 | 22.90M | -3.78% |
Apr 16, 2024 | 23.80M | -7.75% |
Apr 15, 2024 | 25.80M | 2.79% |
Apr 12, 2024 | 25.10M | 8.66% |
Apr 11, 2024 | 23.10M | 2.21% |
Apr 10, 2024 | 22.60M | -6.61% |
Apr 9, 2024 | 24.20M | 1.68% |
Apr 8, 2024 | 23.80M | -6.30% |
Apr 5, 2024 | 25.40M | -4.15% |
Apr 4, 2024 | 26.50M | 2.71% |
Apr 3, 2024 | 25.80M | 2.38% |
Apr 2, 2024 | 25.20M | 6.78% |
Apr 1, 2024 | 23.60M | -2.88% |
Mar 28, 2024 | 24.30M | -4.33% |
Mar 27, 2024 | 25.40M | -4.87% |
Mar 26, 2024 | 26.70M | 2.69% |
Mar 25, 2024 | 26.00M | -1.14% |
Mar 22, 2024 | 26.30M | 1.94% |
Mar 21, 2024 | 25.80M | 3.61% |
Mar 20, 2024 | 24.90M | 2.47% |
Mar 19, 2024 | 24.30M | 1.25% |
Mar 18, 2024 | 24.00M | 1.69% |
Mar 15, 2024 | 23.60M | -2.48% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Alterity Therapeutics | 23.15M |
Lisata Therapeutics | 23.09M |
Biora Therapeutics | 23.04M |
Bullfrog AI | 22.92M |
Cue Health | 22.92M |
Indaptus Therapeutics | 22.71M |
NKGen Biotech | 22.55M |
Cumberland Pharmaceuticals | 22.26M |